A significant body of literature has explored the application of CNNs to distinguish between different breast cancer subtypes, such as invasive ductal carcinoma versus lobular carcinoma, and to predict molecular markers HER2, ER, and PR status (22). This evidence concerns the gene ERBB2 and breast cancer.